Gilead (GILD): Sofosbuvir Doomsday Litigation Scenario Off the Table, Says RBC
Go back to Gilead (GILD): Sofosbuvir Doomsday Litigation Scenario Off the Table, Says RBC| Gilead Sciences (NASDAQ: GILD) | Delayed: 147.60 +4.16 (2.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.44 | 52 Week High | $108.63 | |||
| Open | $145.10 | 52 Week Low | $71.39 | |||
| Day High | $148.97 | P/E | 81.55 | |||
| Day Low | $144.30 | EPS | $1.81 | |||
| Volume | 6,738,793 | |||||
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 58.20 +2.67 (4.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.53 | 52 Week High | $35.13 | |||
| Open | $56.53 | 52 Week Low | $28.10 | |||
| Day High | $58.41 | P/E | N/A | |||
| Day Low | $56.47 | EPS | $0.00 | |||
| Volume | 2,203,357 | |||||
